Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gottlieb

Showing results (331-340 of 349) with videos related to

Pageof 35
Sort By:
The New England Journal of Medicine|December 22, 2021
Early Remdesivir to Prevent Progression to Severe Covid-19 in OutpatientsRobert L Gottlieb, Carlos E Vaca, Roger Paredes, et al.
The New England Journal of Medicine|July 14, 2021
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19Michael Dougan, Ajay Nirula, Masoud Azizad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2021
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral LoadMichael Dougan, Masoud Azizad, Bharat Mocherla, et al.
JAMA|August 22, 2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical TrialChristoph D Spinner, Robert L Gottlieb, Gerard J Criner, et al.
The Lancet. Global Health|July 23, 2024
WHO global research priorities for sexually transmitted infectionsSami L Gottlieb, Erica Spielman, Laith Abu-Raddad, et al.
The New England Journal of Medicine|October 27, 2023
Patisiran Treatment in Patients with Transthyretin Cardiac AmyloidosisMathew S Maurer, Parag Kale, Marianna Fontana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 25, 2020
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of CareSusan A Olender, Katherine K Perez, Alan S Go, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2022
A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19Michael E Bowdish, Christina E Barkauskas, Jessica R Overbey, et al.
Archives of General Psychiatry|July 16, 2003
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late lifeDennis S Charney, Charles F Reynolds, Lydia Lewis, et al.
BMJ Global Health|April 5, 2024
Effectiveness and safety of COVID-19 vaccines on maternal and perinatal outcomes: a systematic review and meta-analysisSilvia Fernández-García, Laura Del Campo-Albendea, Dharshini Sambamoorthi, et al.
Pageof 35

Showing results (331-340 of 349) with videos related to

Sort By:
Pageof 35
The New England Journal of Medicine|December 22, 2021
Early Remdesivir to Prevent Progression to Severe Covid-19 in OutpatientsRobert L Gottlieb, Carlos E Vaca, Roger Paredes, et al.
The New England Journal of Medicine|July 14, 2021
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19Michael Dougan, Ajay Nirula, Masoud Azizad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2021
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral LoadMichael Dougan, Masoud Azizad, Bharat Mocherla, et al.
JAMA|August 22, 2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical TrialChristoph D Spinner, Robert L Gottlieb, Gerard J Criner, et al.
The Lancet. Global Health|July 23, 2024
WHO global research priorities for sexually transmitted infectionsSami L Gottlieb, Erica Spielman, Laith Abu-Raddad, et al.
The New England Journal of Medicine|October 27, 2023
Patisiran Treatment in Patients with Transthyretin Cardiac AmyloidosisMathew S Maurer, Parag Kale, Marianna Fontana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 25, 2020
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of CareSusan A Olender, Katherine K Perez, Alan S Go, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2022
A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19Michael E Bowdish, Christina E Barkauskas, Jessica R Overbey, et al.
Archives of General Psychiatry|July 16, 2003
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late lifeDennis S Charney, Charles F Reynolds, Lydia Lewis, et al.
BMJ Global Health|April 5, 2024
Effectiveness and safety of COVID-19 vaccines on maternal and perinatal outcomes: a systematic review and meta-analysisSilvia Fernández-García, Laura Del Campo-Albendea, Dharshini Sambamoorthi, et al.
Pageof 35